Seeking Alpha

Seeking Alpha Portfolio App for iPad

Ketan Desai

Ketan Desai picture

Profile

Send Message

View as an RSS Feed

View Ketan Desai's Articles BY TICKER:

Fiscal Cliff And The Obesity Epidemic
on Wed, Dec 26, 2012 • 4 Comments
Will Physicians Prescribe Vivus' Qsymia?
on Wed, Sep 12, 2012 • VVUS • 82 Comments
Pfizer's Success With Its JAK Inhibitor
on Thu, Aug 16, 2012 • ABT, AMGN, BMY • 1 Comment
Results Of My Options Strategy For Vivus
on Tue, May 1, 2012 • VVUS • 9 Comments
Another Option Strategy For Vivus
on Tue, Apr 3, 2012 • VVUS • 6 Comments
Merck's Oral Immunotherapy For Allergic Rhino-Conjunctivitis
on Tue, Mar 6, 2012 • MRK • 2 Comments
The Battle For The Anti-Coagulation Market
on Thu, Feb 23, 2012 • BMY, PFE, SNY • 6 Comments
India's Iran Gambit: The Hunt For Oil
on Mon, Feb 13, 2012 • ICN, INR • 3 Comments
Targacept Stumbles Again
on Tue, Dec 20, 2011 • AZN, TRGT • 3 Comments
Depressing Results From Targacept's Phase III Study
on Wed, Nov 9, 2011 • AZN, FRX, TRGT • 2 Comments
Investing In A Charlie Brown Market: Options In Leveraged ETFs
on Sun, Oct 23, 2011 • TZA, TNA • 7 Comments
One Way To Profit With Leveraged ETFs
on Thu, Oct 6, 2011 • TZA, TNA, FAS • 22 Comments
When to Buy Biotechnology Stocks?
on Mon, Aug 15, 2011 • ALXN, MNKD, ARNA • 1 Comment
Earnings: What Happened to Dendreon?
on Thu, Aug 4, 2011 • DNDN • 2 Comments
Accountable Care Organizations: The Effect on Medical Care and Healthcare-Related Stocks
on Mon, Jun 6, 2011 • GE, LH, DGX • 6 Comments
How Investors Should Play India's Troubling Demographics
on Wed, Apr 6, 2011 • TTM, AGU, POT • 13 Comments
Who Will Win the Hepatitis C Market?
on Mon, Mar 14, 2011 • VRTX, MRK, VRUS • 10 Comments
Human Genome Sciences Options Prior to the FDA Decision
on Tue, Mar 8, 2011 • GSK • 17 Comments
Will Merck Succeed Where Pfizer Did Not?
on Wed, Feb 9, 2011 • MRK, PFE • 1 Comment
What Now for Egypt?
on Sun, Jan 30, 2011 • EGPT, GAF, MES • 7 Comments
Abbott the Only One Left in the Osteoarthritis Game
on Wed, Dec 29, 2010 • PFE, JNJ, ABT • 17 Comments
India's Contradictory Economics
on Mon, Nov 15, 2010 • 8 Comments
4 Lessons From a Review of Arena Articles
on Sun, Sep 19, 2010 • ARNA • 42 Comments
The Economic and Political Implications of Afghan Gold
on Mon, Jun 14, 2010 • BHP, VALE, RIO • 12 Comments
Human Genome Sciences: Tests Raise Questions About New Lupus Drug
on Fri, Apr 23, 2010 • AMGN, GSK, ABT • 11 Comments
Eli Lilly and GlaxoSmithKline: A Tale of Two Different Pharmas
on Wed, Feb 3, 2010 • GSK, LLY • 5 Comments
J&J Has Success with Psoriasis Treatment
on Tue, Jan 19, 2010 • AMGN, ABT, JNJ • 2 Comments
On Investment and Optimism
on Thu, Jan 7, 2010 • TBT, TIP • 5 Comments
Another Positive Indication for Amgen's Denosumab
on Fri, Sep 11, 2009 • AMGN, NVS • Comment!
Myriad Genetics: I Told You So
on Tue, Jul 1, 2008 • MYGN • 11 Comments
Limited Investment Opportunities in Indian Pharmaceutical Services
on Wed, Jun 25, 2008 • IFN, RDY, PPDI • 4 Comments
Cangene: Canada's Answer to Bioterrorism
on Sun, Jun 22, 2008 • CGNOF.PK • Comment!